Spravato (esketamine) is a prescription drug approved to treat specific forms of depression. It comes as a nasal (nose) spray. Spravato is usually given on a dosing schedule that varies by the ...

Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...

Spravato (esketamine) is a prescription drug that’s approved to treat depression in certain situations. Spravato can cause side effects that range from mild to serious. Examples include dizziness and ...

Credit: Johnson & Johnson. The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, placebo-controlled, phase 4 TRD4005 trial. Spravato ...

Welcome, I'm Dr. Fortunate, a Doctoral-Certified PMHNP-BC specializing Psychiatry services, ADHD Testing/Medication Management and Certified Spravato (Nasal Ketamine) Treatment for Severe Depression.

The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The spray, ...